Diadema Partners’s UroGen Pharma URGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.06M	Buy	150,000 +73,780	+97%	+$1.01M	0.63%	20
2025 Q1	$843K	Buy	76,220 +26,220	+52%	+$290K	0.22%	29
2024 Q4	$533K	Buy	+50,000	New	+$533K	0.23%	35